Cargando…
Response to Immune Checkpoint Inhibitors Is Affected by Deregulations in the Antigen Presentation Machinery: A Systematic Review and Meta-Analysis
Immune checkpoint inhibitors (ICI) targeting programmed death 1 (PD-1), its ligand (PD-L1), or cytotoxic T-lymphocyte antigen 4 (CTLA-4) have shown promising results against multiple cancers, where they reactivate exhausted T cells primed to eliminate tumor cells. ICI therapies have been particularl...
Autores principales: | Rasmussen, Maria, Durhuus, Jon Ambæk, Nilbert, Mef, Andersen, Ove, Therkildsen, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821706/ https://www.ncbi.nlm.nih.gov/pubmed/36615128 http://dx.doi.org/10.3390/jcm12010329 |
Ejemplares similares
-
Colorectal cancer in adolescents and young adults with Lynch syndrome: a Danish register-based study
por: Durhuus, Jon Ambæk, et al.
Publicado: (2021) -
Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors
por: Rasmussen, Maria, et al.
Publicado: (2023) -
Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort
por: Therkildsen, Christina, et al.
Publicado: (2020) -
Immunoprofiles of colorectal cancer from Lynch syndrome
por: Walkowska, Joanna, et al.
Publicado: (2018) -
Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types
por: Therkildsen, Christina, et al.
Publicado: (2017)